Histological differences between sarcoidosis and lung cancer-related sarcoid reaction

2020 ◽  
Vol 58 (5) ◽  
pp. 421-424
Author(s):  
Yoshiaki Kinoshita ◽  
Hiroshi Ishii ◽  
Yoshinobu Eishi ◽  
Keisuke Uchida ◽  
Masayo Yoshimura ◽  
...  
Keyword(s):  
2007 ◽  
Vol 37 (2) ◽  
pp. 90-95 ◽  
Author(s):  
Yoshito Tomimaru ◽  
Masahiko Higashiyama ◽  
Jiro Okami ◽  
Kazuyuki Oda ◽  
Koji Takami ◽  
...  

Haigan ◽  
1994 ◽  
Vol 34 (7) ◽  
pp. 1053-1058 ◽  
Author(s):  
Masaharu Inagaki ◽  
Kiyofumi Mitsui ◽  
Eiichi Akaogi ◽  
Shigemi Ishikawa ◽  
Tatsuo Yamamoto ◽  
...  

2013 ◽  
Vol 21 (6) ◽  
pp. 732-734 ◽  
Author(s):  
Takuro Yukawa ◽  
Katsuhiko Shimizu ◽  
Yuji Hirami ◽  
Ai Maeda ◽  
Koichiro Yasuda ◽  
...  

2010 ◽  
Vol 53 (2) ◽  
pp. 115-118 ◽  
Author(s):  
Naohiro Kobayashi ◽  
Ryota Nakamura ◽  
Koichi Kurishima ◽  
Yukio Sato ◽  
Hiroaki Satoh

Background: Although sarcoidosis as well as lung cancer are frequently encountered common diseases, their metachronous or synchronous occurrence in the same patient is very rare. Methods: The charts of lung cancer patients, diagnosed between 1980 and 2007 in our hospital, were reviewed. Results: We found 3 cases with sarcoidosis and lung cancer. The first case had lung cancer 16 years after the diagnosis of sarcoidosis. The second case had two different metachronous lung cancers 18 and 10 years after the diagnosis of sarcoidosis. The third case detected these two diseases simultaneously. In simultaneously detected cases, it is difficult to determine whether noncaseating epithelioid cell granulomas coexisting with lung cancer represent sarcoid reaction or genuine systemic sarcoidosis. Conclusions: Either causality or coincidence, lung cancer, a condition that can be observed in patients with sarcoidosis, should be considered in the differential diagnosis when suspicious findings of it are discovered.


JAMA ◽  
1966 ◽  
Vol 195 (6) ◽  
pp. 471-475 ◽  
Author(s):  
M. J. Krant

2016 ◽  
Vol 1 (13) ◽  
pp. 162-168
Author(s):  
Pippa Hales ◽  
Corinne Mossey-Gaston

Lung cancer is one of the most commonly diagnosed cancers across Northern America and Europe. Treatment options offered are dependent on the type of cancer, the location of the tumor, the staging, and the overall health of the person. When surgery for lung cancer is offered, difficulty swallowing is a potential complication that can have several influencing factors. Surgical interaction with the recurrent laryngeal nerve (RLN) can lead to unilateral vocal cord palsy, altering swallow function and safety. Understanding whether the RLN has been preserved, damaged, or sacrificed is integral to understanding the effect on the swallow and the subsequent treatment options available. There is also the risk of post-surgical reduction of physiological reserve, which can reduce the strength and function of the swallow in addition to any surgery specific complications. As lung cancer has a limited prognosis, the clinician must also factor in the palliative phase, as this can further increase the burden of an already compromised swallow. By understanding the surgery and the implications this may have for the swallow, there is the potential to reduce the impact of post-surgical complications and so improve quality of life (QOL) for people with lung cancer.


1994 ◽  
Vol 8 (3) ◽  
pp. 507-532 ◽  
Author(s):  
Gary M. Strauss ◽  
Arthur T. Skarin
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document